Prosecution Insights
Last updated: August 18, 2026

Examiner: HOPPE, EMMA RUTH

Tech Center 1600 • Art Units: 1682 1683

This examiner grants 42% of resolved cases

Performance Statistics

41.9%
Allow Rate
-18.1% vs TC avg
77
Total Applications
+47.0%
Interview Lift
1409
Avg Prosecution Days
Based on 31 resolved cases, 2023–2026

Rejection Statute Breakdown

14.5%
§101 Eligibility
11.4%
§102 Novelty
31.3%
§103 Obviousness
29.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17640016 CRISPR EFFECTOR SYSTEM BASED MULTIPLEX CANCER DIAGNOSTICS Non-Final OA DANA-FARBER CANCER INSTITUTE, INC.
17555945 METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING Non-Final OA Illumina Cambridge Limited
17786473 METHOD OF MEASURING CELL-FREE DNA IN SURGICAL DRAIN FLUID TO SELECT ADJUVANT THERAPY Non-Final OA Washington University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month